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CHRONIC HEALTH CONDITIONS
By Candemir C¸ig˘s¸ar1 and Jerald F. Lawless2
Women’s College Hospital and Princess Margaret Hospital,
and University of Waterloo
In some settings involving recurrent events, the occurrence of one
event may produce a temporary increase in the event intensity; we
refer to this phenomenon as a transient carryover effect. This paper
provides models and tests for carryover effect. Motivation for our
work comes from events associated with chronic health conditions,
and we consider two studies involving asthma attacks in children in
some detail. We consider how carryover effects can be modeled and
assessed, and note some difficulties in the context of heterogeneous
groups of individuals. We give a simple intuitive test for no carryover
effect and examine its properties. In addition, we demonstrate the
need for detailed modeling in trying to deconstruct the dynamics of
recurrent events.
1. Introduction. Recurrent events experienced by individuals, units or
systems occur in many fields [Cook and Lawless (2007)]. For example, re-
peated failures can occur for equipment or for software systems [Ascher and
Feingold (1984), Baker (2001), Lindqvist (2006)]. In medical contexts, indi-
viduals may experience multiple episodes of hospitalization, recurrent infec-
tions or children may suffer repeated attacks of asthma [Duchateau et al.
(2003)]. Models for recurrent events are discussed in books such as Cox and
Isham (1980) and Daley and Vere-Jones (2003). Cox and Lewis (1966), Karr
(1991) and Cook and Lawless (2007) discuss related methods of analysis.
In certain settings an event intensity is temporarily increased (or in some
cases, decreased) after some condition or event occurs. Such transient effects
Received July 2011; revised April 2012.
1Supported by Cancer Care Ontario and the Ontario Institute for Cancer Research
(through funding provided by the Ministry of Health and Long-Term Care and the Min-
istry of Research and Innovation of the Government of Ontario).
2Supported by the Natural Sciences and Engineering Research Council of Canada.
Key words and phrases. Internal covariates, Poisson processes, renewal processes, score
tests.
This is an electronic reprint of the original article published by the
Institute of Mathematical Statistics in The Annals of Applied Statistics,
2012, Vol. 6, No. 4, 1641–1663. This reprint differs from the original in pagination
and typographic detail.
1
2 C. C¸IG˘S¸AR AND J. F. LAWLESS
may be due to factors that are either external or internal to the individuals
or systems in question. Transient effects due to external factors have re-
ceived considerable recent attention. For example, Farrington and Whitaker
(2006) and Farrington and Hocine (2010) have examined potential adverse
health effects following administration of the mumps, measles and rubella
(MMR) vaccine to children. Farrington, Whitaker and Hocine (2009) con-
sider adverse effects related to drug treatments. Our focus in this paper is
on internal factors. These are not usually observable, and evidence for their
existence is sought by examining whether event intensities are temporarily
increased soon after an event occurs. We call such effects carryover effects,
which is also a term used to describe transient effects due to external factors
such as vaccinations or residual effects of drugs [Cook and Lawless (2007),
Section 3.8.2]. This phenomenon has also often been discussed for hardware
or software systems, where repairs or modifications undertaken to deal with
a failure may not resolve the problem or may even create new problems [e.g.,
Baker (1996, 2001), Pen˜a (2006)].
The motivation for the present paper is from attempts to identify po-
tential carryover effects related to events occurring in subjects with chronic
medical conditions. Such effects are inherently difficult to assess because
of complex factors that may influence event occurrence. These include un-
observable covariates that can produce wide heterogeneity in event rates
across individuals and the presence of temporal trends that may be related
to the age of a process or to external factors such as seasonal effects. In ad-
dition, clinical events are often related to unobservable processes concerning
a person’s health and fluctuations in such processes can produce clustering
of events. This paper is motivated specifically by studies of adverse events
in children. Two studies that we consider here involve randomized treat-
ment trials for the prevention of asthma attacks; a third study that will be
discussed more briefly later in the paper involves failures associated with
shunts which are used to drain excess cerebrospinal fluid in children with
hydrocephalus [Tuli et al. (2000)].
In the first asthma prevention trial, infants who were considered at high
risk for asthma were randomized at 6 months of age to receive either a
placebo or drug treatment [Duchateau et al. (2003)]. They then were fol-
lowed for 18 months, and occurrences of any asthma attacks (according to
specified symptoms) were recorded. In addition to the assessment of any
drug effect, other points of interest are the evolution of the asthma recur-
rent event rate over time and how the occurrence of an event influences
the event rate [Duchateau et al. (2003), page 356]. In the second study
[Verona et al. (2003)], children aged 4–11 years were randomized to receive
either 200 or 400 µg per day of fluticasone propionate (FP) for the pre-
vent of asthma exacerbations. The original protocol called for 3 months of
follow-up per child, but this was later amended to 12 months. Most of the
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exacerbations in question were defined as “moderate;” these were defined as
occurring if a child experienced a period of two consecutive days on which ei-
ther (i) their morning percentage predicted expiratory flow (PEF, a measure
of lung function) fell more than 20% below their baseline value measured
at randomization, or (ii) they had an increase in inhaler (β2-agonist) us-
age.
In each of these studies we will examine whether there is an indication
that individuals are temporarily at a higher risk of a new event (exacerba-
tion) following the resolution of a previous exacerbation. Insights into this
can affect strategies for the prevention and treatment of exacerbations. As
an illustration we show a simple synopsis of data from the first asthma trial,
in which 119 children were randomized to the placebo control group and
113 were randomized to the treatment group. The total numbers of asthma
attacks were 483 (control group) and 336 (treatment group). The total ob-
served and expected (calculated under a hypothesis of no carryover effect,
as described in Section 5.1) number of attacks which occurred within two
weeks of the preceding attack are as follows:
Control group: Observed = 121, Expected = 80.3,
Treatment group: Observed = 76, Expected = 40.5.
The data show an excessive number of events soon after the preceding event.
The presence of a carryover effect can be assessed fairly readily in single
systems which experience large numbers of events [e.g., Baker (2001)]. How-
ever, in medical contexts we typically have a large number of individuals,
each with a small number of events. The purpose of this paper is to discuss
models through which the presence of a carryover effect can be assessed in
settings involving multiple heterogeneous individuals, as seen in the preced-
ing studies. We make three novel contributions. First, we show that internal
carryover effects can be difficult to distinguish from subject heterogeneity
in settings where the average number of events per subject is fairly small.
Second, we show that the data often have limited information about the du-
ration of an effect, so reliance on background information is crucial. Finally,
we provide tests for no carryover effect which are simple to interpret and
reasonably robust.
In Section 2 we consider models for transient carryover effects, discuss
their connection to the concept of event clustering, and show how hetero-
geneity makes the assessment of transient effects more difficult. Section 3
considers some simple tests and Section 4 presents simulation results on
their properties. Section 5 examines the studies on asthma in infants. Sec-
tion 6 contains concluding remarks and discusses a study of cerebrospinal
fluid shunt failures in pediatric patients. In the interests of exposition, some
technical derivations are placed in the Appendix.
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2. Models for carryover effects. We use standard notation for recurrent
events. We assume that an individual process is observed over time interval
[0, τ ], and let N(t) denote the number of events in (0, t]. The history of
events over [0, t) is denoted by H(t) and the event intensity function [Cook
and Lawless (2007), page 10] is given by
λ(t|H(t)) = lim
∆t↓0
Pr{N(t+∆t−)−N(t−) = 1|H(t)}
∆t
.(2.1)
The intensity fully specifies continuous time processes where at most one
event can occur at a given time. The times of events are denoted T1 < T2 <
· · · , and B(t) = t− TN(t−) is the elapsed time since the most recent event
prior to t. Familiar models include Poisson processes, where λ(t|H(t)) = ρ(t)
for some function ρ, and renewal processes, where λ(t|H(t)) = h(B(t)) for
some function h.
Carryover effects can be modeled in a number of ways. A model that is
very useful when events may display time trends is a modulated Poisson
process. In this case, (2.1) takes the form
λ(t|H(t)) = ρ0(t) exp(β
′Z(t)),(2.2)
where Z(t) is a q × 1 vector of time-varying covariates that is allowed to
contain functions of the event history H(t) as well as external covariates.
More specifically, we can consider models for which Z(t) includes terms that
are zero except for a limited time period following the occurrence of an event;
such terms specify the carryover effects. A simple but very useful model is
one where Z(t) in (2.2) takes the form
Z(t) = I(N(t−)> 0)I(B(t)≤∆),(2.3)
where ∆> 0 is a specified value. In that case the intensity function follow-
ing an event temporarily changes from ρ0(t) to e
βρ0(t). Tests of the null
hypothesis H0 :β = 0, developed below, provide simple and intuitive tests of
no carryover effect.
Other similar models with carryover effects can also be specified. For
example, a model (2.2) with Z(t) = I(N(t−)> 0) exp(−γB(t)) or an additive
linear self-exciting process [Cox and Isham (1980), Section 3.3; Ogata (1983)]
with λ(t|H(t)) = ρ0(t) + β
∑N(t−)
j=1 e
−γ(t−tj ) also produces transient effects
following events, while allowing possible time trends as in (2.2). Such models
are more difficult to handle than (2.2) and (2.3), and do not impose a time
limit on the duration of an effect, but have been found useful in areas such
as seismology [Ogata (1983)].
There is a close connection between what we term carryover effects and
cluster processes [Cox and Isham (1980), Section 3.4]. In a cluster process
the events occur in clusters, or groups of events that are close together in
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time. Carryover effects in essence produce a type of clustering, and models
such as (2.3) or the linear self-exciting process can be viewed as cluster pro-
cesses in which each new event produces a subprocess going forward in time,
with a decreasing rate function [e.g., Cox and Isham (1980), pages 69, 77].
On the basis of observed events alone, it is impossible to say what produces
observed clustering, and we must rely on context-specific background to sug-
gest plausible mechanisms. We view internal carryover effects as arising when
a “remedy” for an adverse effect is unsuccessful or partially successful, and
consider models that facilitate interpretation within that framework. Many
models for cluster processes are harder to handle [e.g., Cox and Isham (1980),
Section 3.4; Xie, Sun and Naus (2009)], especially when the rate of events
is not stationary, and there is heterogeneity. Standard clustering models do
not address these points. Our models are straightforward to handle and pro-
vide insight, but as always, models should be checked, and other approaches
may be needed in some situations. We note as well that although we focus
on the case where the intensity temporarily increases following an event, in
some contexts it could decrease, with β in (2.2) being negative in that case.
Another way to consider carryover effects is through the distribution of
gap timesWj = Tj−Tj−1 (with T0 = 0) between successive events. Gap time
models [Cook and Lawless (2007), Chapter 4] are particularly useful in set-
tings where an adverse event results in some corrective action which ideally
returns an individual to a “good as new” state [e.g., Pen˜a (2006)]. Gap time
models in which the times between successive events have distributions with
substantial mass near zero could be considered as suggesting a carryover
effect [e.g., see Baker (2001), Lindqvist (2006), Pen˜a (2006)]. They contain
more parameters and are more difficult to handle than (2.2) and (2.3), and
do not accommodate calendar time trends as readily, but are often useful.
In the special stationary case where ρ0(t) in (2.2) is a constant α, the model
with Z(t) given by (2.3) is a delayed renewal process where the times Wj
(j = 2,3, . . .) between successive events are independent random variables
with a hazard function of the form h(w) = αeβI(w ≤∆)+αI(w >∆).
In applications involving multiple systems or individuals, heterogeneity is
often apparent [e.g., Lawless (1987), Baker (2001), Lindqvist (2006), Cook
and Lawless (2007), Section 3.5]. For example, individual processes may be
(approximately) Poisson, but their rate functions may vary. Such variation is
typically due to unmeasured differences in the individuals or the environment
in which the processes operate. It is imperative to consider the possibility
of heterogeneity because, as we show below, it can create an appearance of
a carryover effect when no such exists.
The simplest and most useful extension of modulated Poisson process
models (2.2) to include heterogeneity is where independent processes i =
1, . . . ,m have rate functions
ρi(t|Hi(t)) = αiρ0(t) exp(βZi(t)),(2.4)
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where α1, . . . , αm are positive-valued variables. Models for which the αi are
fixed parameters can be problematic because the αi cannot be estimated
consistently. An alternative is to assume the αi are independent and iden-
tically distributed random effects with some distribution function G(α;φ),
where φ is a vector of parameters [Cook and Lawless (2007), Section 3.5],
and we consider this for most analyses.
We now show why heterogeneity that is not taken into account can mis-
leadingly suggest a carryover effect. Suppose for illustration that the model
(2.4) with β = 0 and αi following a gamma distribution describes a situa-
tion. Without loss of generality, we take the αi to have mean 1 and variance
φ, and then [Cook and Lawless (2007), page 79] we find that the intensity
function for the process with the unobservable αi integrated out is
λi(t|Hi(t)) =E(αi|Hi(t))ρ0(t)
(2.5)
=
{
φ−1 +Ni(t
−)
φ−1 +
∫ t
0 ρ0(u)du
}
ρ0(t).
Note that when an event occurs, the numerator term in brackets in (2.5)
increases by one, thus increasing the intensity. As t increases up to the next
event, the denominator in brackets increases, so the overall effect is that the
intensity increases immediately after an event occurs and then decreases.
This is the type of behavior we associate with a carryover effect. The larger
the degree of heterogeneity across the individuals (i.e., the larger φ is), the
larger is the increase following an event. As t becomes arbitrarily large,
the term in brackets converges in probability to αi so the appearance of a
carryover effect is mainly in the earlier events. However, failure to incorpo-
rate heterogeneity in models can produce spurious evidence of an effect. To
demonstrate, we ran a small simulation by generating 1000 realizations of a
random effect model without carryover effects; we used model (2.4) where
the αi have a gamma distribution with mean 1 and variance φ and parame-
ters ρ0(t) = γ and β = 0 (no carryover effect). We considered eight scenarios
with various combinations of γ, φ and m (γ = 2, 5, φ= 0.2, 0.5 and m= 100,
500). Observation periods were (0, τi) and the τi times were generated from
a uniform distribution over (0.8,1.2). For τi = 1 the expected number of
events per individual is 2 or 5 when γ = 2 or 5, respectively. For each sam-
ple we obtained the maximum likelihood estimates of parameters and their
standard errors in the carryover effect model (2.2) with (2.3), without in-
corporating heterogeneity. We found that βˆ was positively biased across the
1000 simulations for each scenario, with mean to standard deviation ratios
varying from 0.7 to over 10. Correspondingly, tests of the null hypothesis
H0 :β = 0 incorrectly reject H0 with high probability. Using the same data
sets, we also fitted the carryover effect model with random effects (2.4) with
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ρ0(t) = γ, and in this case the means of βˆ were close to zero for all scenarios.
The results can be found in the supplementary material [C¸ıg˘s¸ar and Lawless
(2012)].
We remark also that heterogeneity is to some extent confounded with
a carryover effect even with a proper model specification. With (2.4), for
example, and gamma distributed αi, the intensity function is
λi(t|Hi(t)) =
{
φ−1 +Ni(t
−)
φ−1 +
∫ t
0 ρ0(u)e
βZi(u) du
}
ρ0(t)e
βZi(t).
As t becomes large the term in brackets once again converges in probability
to αi, so a carryover effect represented by β 6= 0 can be readily assessed.
When t and Ni(t
−) are small, however, the carryover effect and the expres-
sion in brackets can both produce substantial temporary increases in the
event intensity. In many of the applications we consider, there are many
individuals but relatively few events for most individuals, and therefore a
process of careful modeling and model-checking is warranted. Next, we con-
sider some tests of no carryover effect based on (2.4). These are reasonably
robust and have a simple interpretation in terms of the observed data.
3. Tests based on Poisson processes. We consider tests of no carryover
effect based on the Poisson model (2.4), and testing that β = 0. This can be
done either using a parametric model for ρ0(t) or by using a nonparamet-
ric specification, in which case (2.4) is a modulated Andersen–Gill model
with frailty [Cook and Lawless (2007), page 81]. We describe the parametric
setting in detail, so as to show the intuitive form of the test statistics, and
then discuss the semiparametric case. The tests use a specified value for ∆
in (2.3) and (2.4). This is consistent with common practice and the result-
ing tests have the nice form of a difference between observed and expected
numbers of events in the window of length ∆ following an event. However,
we later consider the effects of misspecifying ∆ and in Section 5 we consider
estimation of ∆.
3.1. Fixed effects model. We consider first the fixed effects model (2.4),
for which the αi are treated as unknown parameters. This can be useful
when the number of individual processes m is small but there are many
events per process. The follow-up (censoring) times τi throughout the paper
are assumed to be stopping times [Cook and Lawless (2007), page 48]. The
follow-up times are therefore allowed to be random and to depend on pre-
vious event history. In this case, data on m independent processes give the
log likelihood function
ℓ(α,γ,β) =
m∑
i=1
{
ni logαi +
ni∑
j=1
[log ρ0(tij ;γ) + βZi(tij)]−αiRi(γ,β)
}
,(3.1)
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where α= (α1, . . . , αm)
′ and
Ri(γ,β) =
∫ τi
0
ρ0(t;γ)e
βZi(t) dt.(3.2)
For given γ and β, (3.1) is maximized by α˜i(γ,β) = ni/Ri(γ,β), and sub-
stitution of this into (3.1) gives the profile log likelihood for γ and β as a
constant plus
ℓp(γ,β) =
m∑
i=1
{
ni∑
j=1
[log ρ0(tij ;γ) + βZi(tij)]− ni logRi(γ,β)
}
.(3.3)
A likelihood ratio test of H0 :β = 0 requires estimates γˆ, βˆ that maximize
(3.3) and the estimate γ˜ that maximizes ℓp(γ,0); the estimates are found
easily by general optimization software.
A score test can be based on Uβ(γ˜,0), where Uβ(γ,β) = ∂ℓp(γ,β)/∂β. The
standardized score statistic
Uβ(γ˜,0) =
m∑
i=1
{
ni∑
j=1
Zi(tij)−
ni
∫ τi
0 Zi(t)ρ0(t; γ˜)dt∫ τi
0 ρ0(t; γ˜)dt
}
=Obs(∆)−Exp(∆),
where Obs(∆) =
∑m
i=1
∑ni
j=1Zi(tij) is the observed number of events that
occur within time ∆ of a preceding event, and Exp(∆) is an estimate
of the expected number of such occurrences under the hypothesis of no
carryover effect. For the simple case of a homogeneous Poisson process,
ρ0(t;γ) is one, and we find Exp(∆) = (ni/τi)
∑ni+1
j=2 min(wij ,∆), where wij =
tij − ti,j−1 (j = 1, . . . , ni) and wi,ni+1 = τi − tini . The form “observed minus
expected” for Uβ(γ˜,0) is easily understood and useful. The standardized
form of Uβ(γ˜,0) is [Pen˜a (1998)]
S =
Uβ(γ˜,0)
V̂ar[Uβ(γ˜,0)]1/2
,(3.4)
where V̂ar[Uβ(γ˜,0)] = I˜ββ − I˜γβ I˜
−1
γγ I˜βγ is obtained from the observed infor-
mation matrix for β and γ based on (3.3), evaluated at (γ,β) = (γ˜,0).
A problem with S, and with the likelihood ratio statistic, is that if m→∞
but the τi are fixed, the limiting distributions are not standard normal and
χ2(1), respectively, due to the fact that the αi are not estimated consistently.
The normal and χ2 approximations may be adequate in cases where m is
not too large and the numbers of events per process are fairly large, but sim-
ulations in Section 4 show they are inadequate in settings like those in Sec-
tion 5. However, we can use a simulation (parametric bootstrap) approach
to get p-values. Under H0, the event times Ti1, . . . , Tini , given Ni(τi) = ni,
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are the order statistics for a random sample of size ni from the truncated
distribution with density function [Cox and Lewis (1966), Section 3.3]
fi(t;γ) =
ρ0(t;γ)∫ τi
0 ρ0(s;γ)ds
, 0≤ t≤ τi.
Thus, we can generate random samples from each fi(t; γ˜), i= 1, . . . ,m, and
use these to obtain values of the test statistic in question. For the HPP
case, fi(t;γ) is the uniform distribution on [0, τi]. It should be noted that
p-values obtained from this approach are conditional on the observed values
n1, . . . , nm and so are not strictly comparable to the unconditional p-values
provided by a normal or χ2 approximation, or to p-values for the random
effects model in Section 3.2.
3.2. Random effects model. Random effects models employ a distribu-
tion for the αi in (2.4), which are assumed independent. We assume for
discussion that the αi have a gamma distribution with mean 1 and variance
φ, which is a widely used model; similar developments can be given for other
distributions. In this case the log likelihood function is [Cook and Lawless
(2007), Section 3.5.3]
ℓ(γ,β,φ) =
m∑
i=1
{
ni∑
j=1
[log ρ0(tij ;γ) + βZi(tij)]
+ logΓ(ni + φ
−1)− logΓ(φ−1)(3.5)
+ ni logφ− (ni+ φ
−1) log[1 + φRi(γ,β)]
}
.
Likelihood ratio tests of H0 :β = 0 require maximum likelihood estimates
γˆ, βˆ, φˆ and γ˜, φ˜ (when β = 0); these are readily obtained with general opti-
mization software. The Ri(γ,β) in (3.5) are as defined in (3.2).
Score tests of β = 0 require only γ˜ and φ˜. Appendix B gives the score
statistic
S =Uβ(γ˜,0, φ˜)/V̂ar[Uβ(γ˜,0, φ˜)]
1/2(3.6)
corresponding to (3.4). It is instructive to consider the numerators of (3.4)
and (3.6); the numerator of (3.6) is (see Appendix B)
Uβ(γ˜,0, φ˜) = Obs(∆)−
m∑
i=1
(1 + niφ˜)
∫ τi
0 Zi(t)ρ0(t; γ˜)dt
1 + φ˜
∫ τi
0 ρ0(t; γ˜)dt
.(3.7)
Equation (3.7) differs from the numerator of (3.4) in the calculation of the
second term, Exp(∆). The fixed effects case (3.4) corresponds to the limit
of (3.7) as the estimated variance φ˜ of the αi becomes arbitrarily large. As-
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suming that the gamma distribution for the αi is correct, the statistic S
in (3.6) is asymptotically N(0,1) as m→∞, unlike the fixed effects statis-
tic. In Section 4 we examine the adequacy of the normal approximation in
practical settings. In situations where it is inadequate we can use simulation
(parametric bootstrap) to obtain p-values. In addition, the gamma distribu-
tion will never be exactly correct in practice, so we consider the performance
of (3.6) under departures from the gamma in Section 4.
The Andersen–Gill model with random effects αi [Cook and Lawless
(2007), page 81] can also be used. This model places no parametric restric-
tions on ρ0(t) in (2.4). The R/S-Plus function coxph with the frailty option
implements this, but some work is needed to extract Observed–Expected
components analogous to (3.7); see Appendix B.
3.3. Power of tests and choice of ∆. The tests of no carryover effect in
the preceding section are based on a specified value of ∆ and a family of
alternative hypotheses, but are robust in the sense that the tests of the null
Poisson processes are, under some conditions, consistent against carryover
alternatives that are not in the family represented by (2.2) and (2.3). That
is, as m→∞, the probability H0 is rejected approaches one under the al-
ternative. We illustrate this property via simulation in Section 4, where we
show that the tests in Sections 3.1 and 3.2 retain good power when ∆ is
misspecified and when the random effects distribution (Section 3.2) is mis-
specified. Simulation results (not shown) also indicate the tests retain power
against alternatives where the true form of the process intensity is additive
[λ0(t;γ) + βZi(t)] rather than multiplicative. The model (2.4) should, how-
ever, be checked for consistency with the data; ways to do this are discussed
by Cook and Lawless (2007), Chapters 3 and 5. Carryover effects can also
be tested within alternative modulated Poisson process models such as the
preceding additive model. We also note that assessment of the dynamics
of individual processes with rather few events is inherently difficult, and we
have found it useful to consider models based on gap times as well as Poisson
models. This is illustrated in Sections 5.1 and 6.
In choosing a value of ∆, we must rely on background information that
suggests how long a carryover effect might last for the process under study.
Typically ∆ would be fairly small relative to the average time between events
across individuals. The use of specified durations ∆ for carryover effects is
common [e.g., Farrington and Whitaker (2006), Cook and Lawless (2007),
Section 3.8.2], but there is generally some uncertainty concerning ∆ and
it is best to consider a few separate values. Xu et al. (2011) have recently
considered uncertainty about ∆ for external carryover effects but do not
discuss estimation of ∆. If we treat ∆ as an unknown parameter, there is
often an estimability issue, because the profile likelihood for ∆ supports
quite a wide range of values. We examine this in Section 5, where we find
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that the asthma data sets do not rule out fairly large values of ∆, due partly
to the fact that a carryover effect is partially confounded with heterogeneity.
In addition, as ∆ becomes sufficiently large all events after the first will lie
within the carryover period and an effect β as in (2.2) is confounded with
the scale parameter in ρ0(t).
4. Simulation studies. In this section we present the results of simula-
tion studies conducted to assess when asymptotic normal approximations
for parametric score test statistics are satisfactory, to investigate the tests’
power and to evaluate their robustness with respect to model misspecifica-
tion. Because of space limitations, we provide figures and tables for selected
scenarios, and briefly discuss other scenarios. Additional results are given
in C¸ıg˘s¸ar (2010) and in the supplementary material [C¸ıg˘s¸ar and Lawless
(2012)]. We focus on cases where the null models are homogeneous Poisson
processes; results for nonhomogeneous processes are similar.
We first consider the fixed effects model (2.4) where ρ0(t;γ) = γ, and the
hypothesis of no carryover effect is tested by using the statistic (3.4). In
simulations we took γ = 1, and generated the αi from the gamma distribu-
tion with mean 1 and variance φ= 0.3. This variance represents a degree of
heterogenity often seen in medical data. Similar results were obtained for
φ = 0.6. The αi were generated once for each scenario, so that α1, . . . , αm
are fixed across the repeated samples. To examine the asymptotic normal
approximation for the null distribution of (3.4), we generated 10,000 real-
izations of the m homogeneous Poisson processes. In simulations reported
below, scenarios with various combinations of m, τ , ∆ were considered, with
m= 10, 20, 50, 100 and τi = τ = 10. Results are similar if the τi vary, with
mean equal to 10. In practice, we would be interested in small values of ∆,
and we consider ∆ = 0.0202, 0.0513 and 0.1054. The inter-event times sat-
isfy Pr(Wij ≤∆)= 1− e
−γ∆ = c (say), and with γ = 1, the preceding values
of ∆ give c = 0.02, 0.05 and 0.10, respectively. Table 1 presents empirical
pth quantiles, Qˆp, of the 10,000 score statistics S as well as the estimates
Pˆ (S > Qp), where Qp are the standard normal p-quantiles for p = 0.950,
0.975 and 0.990. The results indicate that as m increases the standard nor-
mal approximation significantly underestimates right tail probabilities 0.05,
0.025 and 0.01. As the discussion in Section 3.1 indicates, this inaccuracy
reflects the fact that, for fixed τ and increasing m, the αi are not estimated
consistently and (3.4) is not asymptotically normal. Most applications of
the type considered here involve fairly large m and rather small numbers of
events per individual, so we need an alternative way to get “honest” p-values.
We recommend the use of simulation to obtain conditional (on n1, . . . , nm)
p-values, as described at the end of Section 3.1.
We next examine the power of (3.4) for tests with size 0.05. In each sce-
nario described below we used the 10,000 realizations of the m processes
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Table 1
Qˆp is the empirical pth quantile of S in (3.4) computed from 10,000 samples when
τ = 10. Pˆ (S >Qp) is the proportion of the values of S in 10,000 samples which are
larger than the pth quantile of a standard normal distribution. The null model (2.4) has
ρ0(t;γ) = 1 and αi ∼ gamma (mean= 1, variance= 0.3)
∆ m Qˆ0.950 Qˆ0.975 Qˆ0.990 Pˆ (S > 1.645) Pˆ (S > 1.960) Pˆ (S > 2.326)
0.0202 10 1.658 2.090 2.632 0.0515 0.0301 0.0174
20 1.569 1.950 2.426 0.0433 0.0248 0.0115
50 1.362 1.720 2.095 0.0292 0.0148 0.0067
100 1.243 1.591 1.990 0.0226 0.0107 0.0049
0.0513 10 1.469 1.873 2.289 0.0367 0.0206 0.0090
20 1.418 1.781 2.166 0.0319 0.0168 0.0072
50 1.234 1.511 1.932 0.0192 0.0096 0.0024
100 0.988 1.265 1.622 0.0094 0.0045 0.0017
0.1054 10 1.361 1.685 2.139 0.0276 0.0142 0.0074
20 1.242 1.599 1.981 0.0220 0.0104 0.0045
50 1.013 1.365 1.703 0.0117 0.0059 0.0026
100 0.751 1.047 1.417 0.0062 0.0027 0.0008
represented in Table 1 to estimate 5% critical values, so as to have (approx-
imately) correct type 1 error 0.05. We then estimated the power of (3.4) by
generating 1000 samples in each scenario from the following model:
λi(t|Hi(t)) = αi exp{βI(Ni(t
−)> 1)I(Bi(t)≤∆0)}, i= 1, . . . ,m,(4.1)
where the αi (i= 1, . . . ,m) are generated from a gamma distribution with
mean 1 and variance φ. We allow ∆0 to differ from ∆ used in (3.4) in order
to check on the effect of misspecifying ∆. We report here only the results
under the model in (4.1) when m= 20. Table 2 and further simulation re-
sults confirm that power increases as τ and m increase. There is some loss of
power if the assumed value of ∆ is too large (i.e., if ∆>∆0), but little loss if
it is too small. We also examined the effect of using the statistic (3.4) when
the αi in (2.4) are actually equal [model (4.1) with αi = α], so that there is
no heterogeneity. There is a slight loss of power relative to the test based on
homogeneous Poisson processes [C¸ıg˘s¸ar (2010)], due to the fact that m val-
ues α1, . . . , αm are estimated instead of a single common value α. However,
since failure to recognize heterogeneity can lead to incorrect rejection of the
hypothesis of no carryover effect, the statistic (3.4) is preferable to the test
statistic based on homogeneous processes.
The fixed effects tests are primarily of interest whenm is small. We recom-
mend the random effects tests more generally, and the remaining discussion
concerns them. We first investigated the random effects test statistic (3.6)
for the case where ρ0(t;γ) = γ in (2.4), and the αi were independent gamma
random variables with mean 1 and variance φ = 0.3. We generated 10,000
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Table 2
Proportion of times in 1000 samples that test statistic (3.4)
exceeded its 0.05 critical value for the alternative model (4.1) under
various scenarios when m= 20 and φ= 0.3. Critical values were
estimated from 10,000 simulated samples
τ = 5 τ = 10
∆ ∆0 e
β = 2 eβ = 4 eβ = 2 eβ = 4
2
3
∆ 0.174 0.675 0.290 0.908
0.0202 ∆ 0.294 0.874 0.481 0.983
4
3
∆ 0.298 0.889 0.473 0.988
2
3
∆ 0.317 0.945 0.531 0.998
0.0513 ∆ 0.543 0.994 0.821 1.000
4
3
∆ 0.509 0.991 0.794 1.000
2
3
∆ 0.505 0.998 0.779 1.000
0.1054 ∆ 0.794 1.000 0.973 1.000
4
3
∆ 0.720 0.999 0.940 1.000
replicates of m homogeneous Poisson processes for γ = 1 and different com-
binations of (∆, m, τ ) to evaluate the null distribution and critical values of
(3.6). Normal quantile–quantile plots indicate that the standard normal ap-
proximation underestimates small p-values slightly for m less than 50 but is
quite good at m= 100. Table 3 shows empirical type 1 errors corresponding
Table 3
Qˆp is the empirical pth quantile of S in (3.6) computed from 10,000 samples when m> 1
and τ = 10. Pˆ (S >Qp) is the proportion of the values of S in 10,000 samples which are
larger than the pth quantile of a standard normal distribution. The null model (2.4) has
ρ0(t;γ) = 1 and αi ∼ gamma (mean= 1, variance= 0.3)
∆ m Qˆ0.950 Qˆ0.975 Qˆ0.990 Pˆ (S > 1.645) Pˆ (S > 1.960) Pˆ (S > 2.326)
0.0202 10 1.835 2.263 2.735 0.0479 0.0303 0.0171
20 1.785 2.177 2.707 0.0625 0.0370 0.0196
50 1.725 2.099 2.589 0.0573 0.0326 0.0159
100 1.703 2.020 2.434 0.0561 0.0284 0.0124
0.0513 10 1.779 2.179 2.656 0.0627 0.0357 0.0192
20 1.694 2.080 2.458 0.0562 0.0312 0.0146
50 1.691 2.027 2.404 0.0554 0.0289 0.0120
100 1.665 1.997 2.361 0.0515 0.0268 0.0111
0.1054 10 1.682 2.049 2.456 0.0534 0.0291 0.0126
20 1.669 2.016 2.366 0.0523 0.0285 0.0110
50 1.642 2.008 2.345 0.0497 0.0280 0.0105
100 1.631 1.942 2.359 0.0479 0.0238 0.0107
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Table 4
Proportion of times in 1000 samples that test statistic (3.6) exceeded its 0.05 critical
value for the alternative model (4.1) under various scenarios when φ= 0.3
m= 20, τ = 10 m= 40, τ = 5 m= 40, τ = 10
∆ ∆0 e
β = 2 eβ = 3 eβ = 2 eβ = 3 eβ = 2 eβ = 3
2
3
∆ 0.282 0.693 0.316 0.692 0.493 0.936
0.0202 ∆ 0.437 0.912 0.496 0.924 0.781 0.994
4
3
∆ 0.460 0.886 0.498 0.914 0.776 0.994
2
3
∆ 0.565 0.959 0.527 0.949 0.805 0.999
0.0513 ∆ 0.828 0.997 0.809 0.998 0.979 1.000
4
3
∆ 0.776 0.997 0.806 0.996 0.972 1.000
2
3
∆ 0.785 0.999 0.808 0.996 0.959 1.000
0.1054 ∆ 0.968 1.000 0.968 1.000 1.000 1.000
4
3
∆ 0.961 1.000 0.942 1.000 0.997 1.000
to normal errors of 0.01, 0.025 and 0.05 for τ = 10 and m= 10, 20, 50, 100.
We also generated 1000 samples from versions of model (4.1) to estimate
the power of the test. In each simulation run, we generated a new set of αi
from the gamma distribution with mean 1 and variance φ. Table 4 shows the
results for different (∆0, e
β , m, τ ) combinations and φ= 0.3. The power is
generally high when eβ = 3, with a little decrease when ∆ is chosen too large.
The power values are higher than those for the fixed effects test in Table 2,
in comparable scenarios. A simulation study for the power of the statistic
(3.6) when φ = 0.6 gave similar results [C¸ıg˘s¸ar (2010) and supplementary
file, C¸ıg˘s¸ar and Lawless (2012), Table S. 4].
In applications like the ones we consider, the number of individuals m
is usually large but the expected number of events per individual is small.
We next generated 10,000 realizations of m processes under the model (4.1)
with φ= 0.6 and β = 0, for the cases m= 100, 200, 500 and E{Ni(τi)} made
equal to 1, 2, 5 by generating τi from a uniform distribution over (0.8, 1.2),
(1.6, 2.4) or (4.0, 6.0), respectively. We calculated test statistic (3.6) for the
values of ∆ = 0.0513, 0.1054 and 0.2231. The larger ∆ values reflect fea-
tures of the data considered in Section 5 and φ = 0.6 is between plausible
values in the two data sets there. Normal probability plots of (3.6) and Ta-
bles S. 5, S. 6 and S. 7 in the supplementary material [C¸ıg˘s¸ar and Lawless
(2012)] show the standard normal approximation to be quite good except
when ∆ = 0.0513, m = 100 and E{Ni(τi)} = 1, 2. Once again, we recom-
mend using simulation (parametric bootstrap) to get “honest” p-values for
such cases. We also conducted a simulation study to investigate the power
of the score statistic (3.6). We used the 10,000 realizations of the null model
discussed above to estimate 5% critical values. We considered m= 100, 200,
CARRYOVER EFFECTS IN RECURRENT EVENT PROCESSES 15
Table 5
Proportion of times in 1000 samples that test statistic (3.6) exceeded its 0.05 critical
value for the alternative model (4.1) under various scenarios when φ= 0.6 and m= 200
E{Ni(τi)}= 1 E{Ni(τi)}= 2 E{Ni(τi)}= 5
∆ ∆0 e
β = 2 eβ = 3 eβ = 2 eβ = 3 eβ = 2 eβ = 3
2
3
∆ 0.585 0.975 0.858 1.000 0.995 1.000
0.0513 ∆ 0.843 0.999 0.990 1.000 1.000 1.000
4
3
∆ 0.809 0.998 0.985 1.000 1.000 1.000
2
3
∆ 0.756 1.000 0.984 1.000 1.000 1.000
0.1054 ∆ 0.952 1.000 1.000 1.000 1.000 1.000
4
3
∆ 0.873 1.000 0.997 1.000 1.000 1.000
2
3
∆ 0.803 1.000 0.999 1.000 1.000 1.000
0.2231 ∆ 0.951 1.000 1.000 1.000 1.000 1.000
4
3
∆ 0.842 0.999 0.999 1.000 1.000 1.000
500 and φ = 0.6, and generated 1000 realizations of processes with the in-
tensity function (4.1) for exp(β) = 1, 2 and 3. Table 5 shows power of (3.6)
for the combinations of [∆, ∆0, exp(β), E{Ni(τi)}] when m= 200 (Tables
S. 8 and S. 9 in the supplementary material give the results when m= 100
and 500, resp.). Overall, test statistic (3.6) maintains high power in these
settings, and is robust with respect to mild misspecification of ∆.
Finally, simulation studies were conducted to examine the performance
of the test statistic (3.6) when the assumption that the αi have a gamma
distribution is not true. To do that, we generated the αi from a lognormal
distribution with mean 1 and variance φ. We then generated 1000 realiza-
tions of m processes when ∆ = 0.0202 and eβ = 1, 2, 3, 4, and calculated
the proportion of the time that (3.6) exceeded the 0.05 critical value. Re-
sults are given in Supplementary Table S. 10, for scenarios with τ = 10 and
m= 20, 40. The column eβ = 1 shows the empirical type 1 errors based on
the 1000 samples; they are close to the nominal significance level 0.05. In
addition, (3.6) maintains high power in this case, and we conclude that mild
misspecification of the distribution of random effects is not a problem; this
agrees with similar results for estimation of rate functions in mixed Poisson
processes without carryover effects [Lawless (1987)].
5. Applications.
5.1. Recurrent asthma attacks in children (I). Duchateau et al. (2003)
discussed data from a prevention trial in infants with a high risk of asthma,
but without a prior attack. The subjects were 6 months of age on entry
to the study. The follow-up period for each subject was approximately 18
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months, and started after random allocation to a placebo control group or
an active drug treatment group. The main aim of the study was to assess the
effect of the drug on the occurrence of asthma attacks, but an interesting
secondary question was whether the occurrence of an event (asthma attack)
influences the future event rate. There were 483 asthma attacks among 119
children in the control group and 336 asthma attacks among 113 children in
the treatment group, during the 18 month follow-up.
The Nelson–Aalen estimates of the mean function [Cook and Lawless
(2007), Section 3.4] for each treatment group are close to linear but that does
not in itself show that the possibly heterogeneous individual rate functions
are constant. Therefore, we fitted models (2.4) in which ρ0(t) took the power
law form γ1γ2t
γ2−1. We found no evidence against the constancy of ρ0(t),
and so the following details are based on constant rates which may vary
across individuals. A caveat concerning the data is that Duchateau et al.
(2003) do not provide the trial entry dates for each subject, so it is not
possible to assess whether there might be a seasonal effect. However, for
the second asthma data set considered in Section 5.2, such information was
available and no seasonal effect was seen. An asthma attack lasts an average
of 6–7 days, and a patient is not considered at-risk for a new attack over
that time. The at-risk indicator Yi(t) takes value 1 if subject i is at risk of
an asthma attack at time t, and the intensity model for subject i that we
consider is therefore
λi(t|Hi(t)) = Yi(t)αiγ exp{βZi(t)}, t≥ 0,(5.1)
where Zi(t) = I{Ni(t
−) > 0}I{Bi(t) ≤∆}, and Bi(t) is the time since the
subject i started their current at-risk period.
We will consider the treatment and control groups separately. To allow for
heterogeneity, we use the tests of Section 3 with the random effects model
(5.1), where αi ∼Gamma(1, φ), for testing H0 :β = 0. Results obtained by
fitting models with a range of values for ∆ are shown in Table 6; to conserve
space, standard errors for estimates φˆ are not given, but in every model
heterogeneity (φ > 0) is strongly significant.
Table 6 gives, for each value of ∆, the estimates of γ, β and φ in model
(5.1), along with the squared score statistic S2 [with S given by (3.6)] and
a corresponding Wald statistic for testing β = 0, defined as Z2 = βˆ2/V̂ar(βˆ).
The models were fitted using R function nlm, which automatically provides
variance estimates via numerical differentiation. The score statistic S is more
easily obtained since only restricted estimates γ˜ and φ˜ are needed, but com-
putational differences are unimportant here. The two statistics agree closely
and strongly contradict the hypothesis (β = 0) of no carryover effect for ev-
ery value of ∆ shown. The p-values obtained from χ2(1) approximations for
S2 and Z2 are virtually zero. As a check on this we also obtained p-values
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Table 6
The results of the no carryover test based on (3.6) for various ∆ values.
Exp(∆) is the second term on the right-hand side of (3.7). Z2 is
the square of βˆ/se(βˆ), and ℓmax = ℓ(γˆ, βˆ, φˆ)
Group ∆ Obs(∆) Exp(∆) γˆ βˆ φˆ S2 Z2 ℓmax
Treatment 7 40 22.858 0.006 0.681 0.476 14.900 14.314 −2009.41
14 76 40.464 0.005 0.904 0.388 40.513 33.338 −1998.52
28 119 67.099 0.005 1.017 0.305 61.968 59.360 −1988.08
42 143 86.213 0.004 1.015 0.284 65.206 62.880 −1985.84
56 162 101.774 0.004 1.029 0.270 68.857 66.694 −1983.75
70 171 114.660 0.004 0.942 0.288 57.882 56.791 −1988.47
Control 7 68 47.173 0.008 0.486 0.521 11.751 11.551 −2726.18
14 121 80.302 0.007 0.637 0.455 29.921 29.142 −2717.95
28 185 130.457 0.007 0.678 0.399 40.284 39.411 −2712.53
42 227 167.050 0.006 0.699 0.373 43.944 43.485 −2710.27
56 260 195.336 0.006 0.745 0.350 49.393 48.478 −2707.26
70 272 218.287 0.006 0.622 0.383 33.698 33.169 −2714.75
for S2 by simulating 1000 samples under the null model with parameter
values γ˜, φ˜. For each value of ∆, there were no samples out of the 1000
generated in which S2 exceeded its observed value in the data set. We also
show observed and expected numbers [Obs(∆), Exp(∆)] of events in car-
ryover periods, assuming no carryover effect; these are given in (3.7). This
provides a nice summary of the excess events observed within time ∆ of a
preceding event.
Table 6 indicates that a wide range of values for ∆ is plausible. We show
the maximum values ℓmax of the log likelihood for each model, and see
that the value of ∆ (among those shown) best supported by the data is
∆ = 56 days in both the treatment and control groups. It is also seen in
Table 6 that estimates βˆ and φˆ are negatively correlated, as our discussion
in Section 2 suggests. As ∆ increases further beyond 70 days, the values
of ℓmax continue to decrease, and ∆ = 100 days still gives values that are
about the same as ∆= 14 days. The values of γ˜ in the treatment and control
groups, respectively, are 0.00608 and 0.00822, indicating an average of about
one event every 165 days per subject in the treatment group, and one event
every 122 days for the control group. The evidence indicates that events
tend to occur closer to the previous event more often than is expected under
a homogeneous Poisson process.
Our results can also be interpreted as indicating that the gap times be-
tween successive asthma attacks do not follow exponential distributions for
individual subjects. Duchateau et al. (2003) fitted models in which gap
times are assumed to be independent Weibull random variables within indi-
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viduals, and heterogeneity is incorporated through individual-level gamma-
distributed random effects. They found strong evidence of a decreasing haz-
ard function for gap times, which is consistent with a carryover effect. The
Duchateau et al. model has p= 4 parameters and ours has three, but AIC
values (−2ℓmax + 2p) are very close. For example, in the control group we
find the AIC for (5.1) with ∆= 14 days as 5441.9 (p= 3) and the AIC for the
Duchateau et al. model as 5437.6 (p= 4). Smaller AIC values are obtained
for models (5.1) with larger values of ∆; for example, when ∆= 56 the AIC
for the control group is 5420.5, the smallest for the models considered here.
Thus, all models indicate that the probability of a new asthma attack is
highest soon after a preceding attack, and then decreases. Whether a delayed
renewal process or a modulated Poisson process best describe the situation
is not clear, nor whether there is a carryover effect of limited duration or a
smooth decreasing hazard function for gap times. Without additional infor-
mation concerning the asthma attacks and their treatment, we also cannot
know the basis of the perceived effect.
5.2. Recurrent asthma attacks in children (II). We now briefly consider
the randomized trial on the effects of 200 versus 400 µg per day of fluticasone
propionate (FP) in preventing asthma attacks in children, mentioned in
Section 1. Verona et al. (2003) describe the study in detail, and the data
have been reanalyzed by Cook and Lawless (2007), Section 5.5.2. None of the
previous analyses has looked at the interesting secondary issue of whether
there is any indication of a carryover effect; we consider this here.
Earlier analyses showed that age and predicted expiratory flow (PEF)
at enrollment had some predictive power for asthma exacerbations and we
included them in our models. Seasonal effects and covariates such as sex and
weight were examined but were not found significant and are excluded here.
We ran analyses based on the modulated Poisson model (2.4) with gamma
random effects and different values of ∆ for the duration of carryover. In
the interest of brevity we focus here on the FP200 group, which had 267
subjects. About one-third had approximately 3 months follow-up, with two-
thirds followed for approximately 12 months. Cook and Lawless [(2007), page
195] show the numbers of asthma attacks per subject; there were a total of
359 in the FP200 group. As an illustration of the semiparametric approach
we used the Andersen–Gill version of (2.4) with additional covariates, so
no parametric assumption concerning ρ0(t) was made. According to the
protocol for the trial, an exacerbation was counted only if it was not within
10 days of the start of a previous exacerbation, so the at-risk indicator Yi(t)
introduced in (5.1) is defined so that Yi(t) equals 1 if and only if subject i
is not within 10 days of a preceding exacerbation.
Table 7 shows results for models fitted with various values of carryover
duration ∆; models were fitted using R function coxph. As in the preced-
ing example, there is strong evidence against the hypothesis of no carryover
CARRYOVER EFFECTS IN RECURRENT EVENT PROCESSES 19
Table 7
Estimation results for Andersen–Gill models
(2.4) with gamma random effects, fitted to
FP200 asthma trial data
∆a βˆ se(βˆ) φˆ Z2b ℓmax
7 0.206 0.185 1.58 1.24 −1800.28
14 0.394 0.144 1.46 2.49 −1797.56
28 0.241 0.133 1.47 3.28 −1799.43
42 0.426 0.130 1.27 10.34 −1796.77
56 0.487 0.132 1.18 13.61 −1796.00
70 0.462 0.134 1.19 11.89 −1796.89
84 0.419 0.136 1.21 9.49 −1797.78
a∆ is in days.
bZ2 = βˆ2/se(βˆ)2.
effect (β = 0), but a wide range of values for ∆ is supported by the data.
The best supported value is about 56 days (8 weeks), as in the study in
Section 5.1. The average rate of events per subject in these data is about
1.8 per year, or about one asthma attack every 29 weeks. Therefore, there
is once again an indication that the risk of a new attack is higher soon
after a previous attack. As in the preceding case, there is also strong ev-
idence of heterogeneity across subjects. This information, in conjunction
with background medical information, may suggest that modifications to
the prevention or treatment of attacks be considered.
6. Concluding remarks. We have considered modulated Poisson process
models and tests for carryover effects, allowing for time trends and hetero-
geneity across processes. The random effects models and tests are recom-
mended for general use; the tests have better power and are better approx-
imated by asymptotic normal theory, especially when m is large. Fixed or
time-varying covariates can be incorporated into our approach, as illustrated
in Section 5.2.
It can be hard to deconstruct the dynamics of event occurrence when
there are few events for most individuals, and the examination of alterna-
tive models is important. An alternative approach that is useful is to examine
the distribution of “gap” times between successive events. The presence of
a carryover effect is suggested by the density or hazard function for the
gap times having substantial mass near zero. Such models do not produce
definitions or tests for a carryover effect or handle time trends as readily
as the models in Section 3. However, examination of gap time models as
in Section 5.1 is often helpful, and in the absence of covariates, nonpara-
metric estimates of hazard or density functions for gap times are useful. As
an additional illustration, we consider data on children with hydrocephalus,
who have shunts inserted to drain excess cerebrospinal fluid. In the study
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Table 8
Estimates of baseline cumulative hazard and piecewise-constant
hazard functions for cerebrospinal fluid shunts
Second shunts Third shunts
a Hˆ02(a) hˆ02(a)
a Hˆ03(a) hˆ03(a)
a
0 0 0
60 0.19263 0.00321 0.30316 0.00505
120 0.26584 0.00122 0.39280 0.00149
180 0.29106 0.00042 0.44324 0.00084
240 0.32343 0.00054 0.47100 0.00046
300 0.35529 0.00053 0.48560 0.00024
360 0.38951 0.00057 0.51582 0.00050
ahˆ0j(a) = [Hˆ0j(a)− Hˆ0j(a− 60)]/60, j = 2, 3.
mentioned in Section 1 [Tuli et al. (2000)], data on 839 children who had
initial shunts inserted during the years 1989–1996 at one Canadian hospital
were analyzed. Such shunts can “fail” due to blockages, infections and other
conditions, necessitating full or partial replacement of the shunt. The data
in question were analyzed previously by Lawless et al. (2001) and Cook and
Lawless (2007), Section 5.4.2. Gap time models are a natural approach in this
case: the occurrence of a failure results in a new shunt, and it makes sense
to examine the lifetime of each subsequent shunt. The previous analyses
were based on Cox models fitted to the survival times of successive shunts,
and they showed that there were several important covariates, including the
cause of a child’s hydrocephalus and the age of the child at the time a shunt
was (surgically) inserted. They also showed a tendency for second or third
shunts to fail sooner than initial shunts. Plots of estimated baseline cumula-
tive hazard functions H˜0j(t) for shunts j = 1,2, . . . [e.g., Cook and Lawless
(2007), Figure 5.9] suggested that the risk of failure was high soon after a
new shunt was inserted, but this was not examined further. Table 8 shows
a discretized estimate of the baseline hazard functions h02(w) and h03(w)
for second and third shunts for a model involving adjustment for impor-
tant covariates and additional allowance for heterogeneity. The covariates
are coded for the two models such that the baseline hazard functions h02(w)
and h03(w) represent the same vector of covariate values. The estimates
are piecewise-constant, with h˜0j(w) = [H˜0j(aj)− H˜0j(aj−1)]/(aj − aj−1) for
aj−1 <w≤ aj and aj = 0,60,120, . . . (days) for j = 0,1,2, . . . . It is seen that
the hazard functions are sharply decreasing. The time to failure of the ini-
tial shunt also shows a decreasing hazard function, but with overall smaller
values. This indicates the risk of shunt failure is highest soon after it is in-
serted, and one explanation is that problems leading to a shunt failure may
in some cases persist and create problems for the new shunt.
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Finally, in many settings events of different types may occur. For exam-
ple, that is the case with shunt failures, which can be due to obstruction,
infection or other causes. In this context we can specify separate covariates
to represent carryover effects related to the different event types. This is
readily done in either the modulated Poisson process framework or the gap
time framework. Table 8 is from a combined-causes analysis of the shunt
failures, but separate causes could be considered similarly.
APPENDIX A: ANDERSEN–GILL MODEL
For the modulated Andersen–Gill model (2.2) for recurrent events, the
Cox partial likelihood function for β gives the score function [Cook and
Lawless (2007), page 71]
Uβ(β) =
m∑
i=1
{∫ τi
0
Zi(t)
[
dNi(t)−
dN¯·(t)e
β′Zi(t)∑m
l=1 Yl(t)e
β′Zl(t)
]}
,(A.1)
where dNi(t) = I (process i has an event at time t), Yl(t) = I(τl ≥ t), and
dN¯·(t) =
∑m
l=1Yl(t)dNl(t). The score statistic at β = 0 is
Uβ(0) =
m∑
i=1
{∫ τi
0
Zi(t)[dNi(t)− ρ˜0(t)dt]
}
,(A.2)
where, taking liberties with notation,
ρ˜0(t)dt=
dN¯·(t)∑m
l=1 Yl(t)
(A.3)
is the estimated baseline rate function at time t. Thus, (A.1) can be rewritten
in “Observed–Expected” form as
Uβ(0) =
m∑
i=1
ni∑
j=1
Zi(tij)−
R∑
r=1
Z·(t
∗
r)
dN¯·(t
∗
r)
Y·(t∗r)
,(A.4)
where t∗1, . . . , t
∗
R are the distinct event times across all processes, and Z·(t) =∑m
i=1Zi(t), Y·(t) =
∑m
i=1 Yi(t), and dN¯·(t) is defined following (A.1). This
approach can be used if there is no evidence of heterogeneity across indi-
viduals. Usually this is not the case and then we should use the approach
described at the end of Appendix B.
APPENDIX B: SCORE STATISTICS FOR GAMMA RANDOM
EFFECTS MODELS
We consider here the score statistic (3.6) arising from the log likelihood
(3.5). The numerator is easily shown to be
Uβ(γ˜,0, φ˜) =
(
∂ℓ(γ,0, φ)
∂β
)
(γ˜,0,φ˜)
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(B.1)
=
m∑
i=1
{
ni∑
j=1
Zi(tij)−
(1 + φ˜ni)∂Ri(γ˜,0)/∂β
1 + φ˜Ri(γ˜,0)
}
,
where Ri(γ,β) is given by (3.2). A variance estimate for Uβ(γ˜,0, φ˜) under
H0 is given by asymptotic theory for counting processes in the case where
m→∞ [Andersen et al. (1993), Chapter 6, Pen˜a (1998)]. This takes the
standard form
V̂ar{Uβ(γ˜,0, φ˜)}= I˜ββ − ( I˜βγ I˜βφ )
(
I˜γγ I˜γφ
I˜φγ I˜γγ
)−1( I˜γβ
I˜φβ
)
.(B.2)
The 2× 2 matrix in (B.2) is the inverse of the negative Hessian matrix
for the log likelihood ℓ(γ,0, φ) evaluated at γ˜, φ˜, and the terms I˜ββ , I˜βγ and
I˜βφ are based on the following, evaluated at γ˜, β = 0, φ˜:
Iββ =
−∂2ℓ(γ,β,φ)
∂β2
=
m∑
i=1
(ni + φ
−1)
{
[φ−1 +Ri(γ,β)][∂Ri/∂β]− [∂Ri/∂β]
2
[φ−1 +Ri(γ,β)]2
}
,
Iβγ =
−∂2ℓ(γ,β,φ)
∂β ∂γ′
=
m∑
i=1
(ni + φ
−1)
{
[φ−1 +Ri(γ,β)][∂
2Ri/∂β ∂γ
′]− [∂Ri/∂β][∂Ri/∂γ
′]
[φ−1 +Ri(γ,β)]2
}
,
Iβφ =
−∂2ℓ(γ,β,φ)
∂β ∂φ
=
m∑
i=1
{
(∂Ri/∂β)[ni −Ri(γ,β)]
[1 + φRi(γ,β)]2
}
.
The Andersen–Gill model of Appendix A with added frailty can be han-
dled by the R/S-Plus Cox model function coxph. This implementation re-
turns an estimate βˆ and standard error, as well as a maximum likelihood
value, so that a likelihood ratio or Wald test of β = 0 can be used. A score
statistic analogous to (B.1) for the Cox model is
Uβ(0) =
m∑
i=1
{
ni∑
j=1
Zi(tij)−
(1 + φ˜ni)
∑
t∗r≤τi
Zi(t
∗
r)(dN·(t
∗
r)/Y·(t
∗
r))
1 + φ˜
∑
t∗r≤τi
(dN·(t∗r)/Y·(t
∗
r))
}
,
where the t∗r , dN·(t
∗
r) and Y·(t
∗
r) are as defined in Appendix A. This statistic
has the form “Observed–Expected ;” the function coxph does not give it as
output so some additional coding is required.
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SUPPLEMENTARY MATERIAL
Additional simulation results (DOI: 10.1214/12-AOAS560SUPP; .pdf).
The supplementary file contains detailed simulation results to support the
discussion in Sections 2 and 4. Each simulation study in the supplementary
file has its own description and title.
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